Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
View Full Paper
Ask AI
Bookmark
Share
Key result
Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death in patients with mildly reduced or preserved ejection fraction.
Authors
Discussion
Loading...
Member takes
Implication
Key Points
Key points are not available for this paper at this time.
Cite This Study
Solomon et al. (2022) studied this question. Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death in patients with mildly reduced or preserved ejection fraction.
View Full Paper
Ask AI
Bookmark
Share